Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Ludolph

Showing results (11-20 of 172) with videos related to

Pageof 18
Sort By:
Drug Metabolism Reviews|August 26, 1999
Neurotoxic mechanisms of degeneration in motor neuron diseasesA C Ludolph, C Münch
Journal of the Neurological Sciences|October 26, 2001
Imaging and neurochemical markers for diagnosis and disease progression in ALSJ Karitzky, A C Ludolph
Der Nervenarzt|January 11, 2012
[Thiamine, pyridoxine and cobalamine. From myths to pharmacology and clinical practice]S Jesse, A C Ludolph
Neurologia I Neurochirurgia Polska|December 6, 2001
Pharmacological treatment of ALSC Münch, A C Ludolph
Der Nervenarzt|July 29, 2011
[Advanced therapy strategies in neurological diseases: present and perspectives]A C Ludolph, J Kassubek
European Journal of Neurology|April 8, 2015
TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?A C Ludolph, J Brettschneider
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 26, 2003
ALS/MND meeting of the European AlS/MND group Reisensburg Castle 30 January - 1 February 2003C O Hanemann, A C Ludolph
Molecular and Cellular Biochemistry|October 6, 1997
Chemical preconditioning: a cytoprotective strategyM W Riepe, A C Ludolph
Neurology|November 24, 1999
Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments againstA C Ludolph, M W Riepe
JAMA|December 14, 1994
Chronic abuse of zolpidemC A Gericke, A C Ludolph
Pageof 18

Showing results (11-20 of 172) with videos related to

Sort By:
Pageof 18
Drug Metabolism Reviews|August 26, 1999
Neurotoxic mechanisms of degeneration in motor neuron diseasesA C Ludolph, C Münch
Journal of the Neurological Sciences|October 26, 2001
Imaging and neurochemical markers for diagnosis and disease progression in ALSJ Karitzky, A C Ludolph
Der Nervenarzt|January 11, 2012
[Thiamine, pyridoxine and cobalamine. From myths to pharmacology and clinical practice]S Jesse, A C Ludolph
Neurologia I Neurochirurgia Polska|December 6, 2001
Pharmacological treatment of ALSC Münch, A C Ludolph
Der Nervenarzt|July 29, 2011
[Advanced therapy strategies in neurological diseases: present and perspectives]A C Ludolph, J Kassubek
European Journal of Neurology|April 8, 2015
TDP-43 in amyotrophic lateral sclerosis - is it a prion disease?A C Ludolph, J Brettschneider
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|September 26, 2003
ALS/MND meeting of the European AlS/MND group Reisensburg Castle 30 January - 1 February 2003C O Hanemann, A C Ludolph
Molecular and Cellular Biochemistry|October 6, 1997
Chemical preconditioning: a cytoprotective strategyM W Riepe, A C Ludolph
Neurology|November 24, 1999
Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments againstA C Ludolph, M W Riepe
JAMA|December 14, 1994
Chronic abuse of zolpidemC A Gericke, A C Ludolph
Pageof 18